^(89)SrCl_2治疗转移性骨肿瘤的应用研究  

Investigation of curative effects of (89)~SrCl_2 in patients with skeletal cancer metastases

作　　者：褚洪涛[1] 王亚南[1] 

机构地区：[1]河南省焦作市人民医院核医学科,454002

出　　处：《核技术》2004年第11期853-857,共5页Nuclear Techniques

摘　　要：观察了69例转移性骨肿瘤病人使用89SrCl2治疗后的镇疼效果、不良反应及不同原发病灶所致骨转移的使用效果。结果表明:治疗69例病人,有32例显效:疼痛完全消失,部分骨转移灶缩小、消失;30例有效:疼痛明显缓解且部分停用或减用止痛剂;7例无效。已死亡的39例除7例无效外,其它病人均有疼痛缓解,停止或减用止痛药物,生活质量明显改善。The analgetic efficiency and adverse effect of 89SrCl2 treatment were observed in 69 patients with metastatic bone tumor from different primary foci. Of 69 patients, pain disappeared completely and metastatic lesions shrinked and disappeared partly in 32 cases; pain abated apparently and analgetic drugs were stopped or reduced in 30 cases; and inefficacy in 7 cases. Of 39 died patients, except ineffective in 7 cases, in the remaining patients either pain abated, analgetics stopped, reduced or life quality improved obviously.

关 键 词：骨转移 ^89SRCL2 疼痛 核素治疗 

分 类 号：R738.1[医药卫生—肿瘤]